Last reviewed · How we verify
Nanocolloid
At a glance
| Generic name | Nanocolloid |
|---|---|
| Also known as | Nanoscint |
| Sponsor | University Hospital, Ghent |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer (NA)
- Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer (NA)
- Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study) (NA)
- Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer (NA)
- Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC (NA)
- Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.
- Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study (NA)
- Radioisotope and Fluorescence Guidance in Rectal Cancer (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |